AbbVie Germany GmbH & Co. KG. is a global, research-based BioPharma company focused on researching and developing innovative therapies for some of the world’s most serious and complex diseases.
In India, the Pharmaceutical business of AbbVie Germany GmbH & Co. KG. is focused on Modulators of 5-HT Receptors, Anti-EGFR Antibody Drug Conjugate (ADC), Carbamate-Substituted Oxindole Derivatives, Amidomethyl-Substituted Xindole Derivatives, Anti-A? Globulomer Antibodies.
AbbVie Germany GmbH & Co. KG. filed patent application numbered 8568/CHENP/2010 that is titled as PHARMACEUTICAL DOSAGE FORM COMPRISING POLYMERIC CARRIER COMPOSITION. This patent application has been granted as Patent Number 297310.
The invention covers the field of pharmaceuticals. This invention relates to pharmaceutical dosage from comprising a solid dispersion product of at least one active ingredient dispersed in a polymeric binder composition.
During patent examination, the patent examiner raised objections under Section 3(d) of the Indian Patents Act, wherein the examiner stated that the claims 1-10 are non- patentable because no enhancement in efficacy (or synergistic effect) has been indicated. Hence these claims fall within the scope of Section 3(d) of the Indian Patent Act.
As a response to said objection, the applicant responded by submitting technical and legal arguments by stating the differentiating on the basis of thermal and mechanical properties to bring the novelty factor.
Advocate Rahul Dev is a Patent Attorney & International Business Lawyer practicing Technology, Intellectual Property & Corporate Laws. He is reachable at rd (at) patentbusinesslawyer (dot) com & @rdpatentlawyer on Twitter.
Quoted in and contributed to 50+ national & international publications (Bloomberg, FirstPost, SwissInfo, Outlook Money, Yahoo News, Times of India, Economic Times, Business Standard, Quartz, Global Legal Post, International Bar Association, LawAsia, BioSpectrum Asia, Digital News Asia, e27, Leaders Speak, Entrepreneur India, VCCircle, AutoTech).
Regularly invited to speak at international & national platforms (conferences, TV channels, seminars, corporate trainings, government workshops) on technology, patents, business strategy, legal developments, leadership & management.
